Free Trial

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY) Hits New 1-Year High - Here's Why

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München logo with Finance background

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report)'s stock price hit a new 52-week high on Monday . The company traded as high as $13.20 and last traded at $13.14, with a volume of 329274 shares traded. The stock had previously closed at $12.84.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. The Goldman Sachs Group downgraded shares of Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th. Barclays raised Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München to a "strong-buy" rating in a research note on Tuesday, January 28th. Four equities research analysts have rated the stock with a hold rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold".

Get Our Latest Stock Report on MURGY

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Trading Up 1.9 %

The stock has a market cap of $91.36 billion, a P/E ratio of 8.88, a P/E/G ratio of 1.72 and a beta of 0.79. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.12 and a current ratio of 1.12. The stock's fifty day moving average is $12.15 and its 200 day moving average is $11.03.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München (OTCMKTS:MURGY - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The financial services provider reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.01). The company had revenue of $16.34 billion for the quarter, compared to analysts' expectations of $19.10 billion. Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München had a net margin of 8.61% and a return on equity of 18.94%. As a group, equities research analysts predict that Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München will post 0.46 earnings per share for the current fiscal year.

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Company Profile

(Get Free Report)

Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München engages in the insurance and reinsurance businesses worldwide. It also offers life and health reinsurance solutions, such as digital underwriting and advanced analytics solutions, health insurance management system, financial market risks, financing, portfolio risk management, digitalized investment-linked solution, MIRA digital suite, MIRA POS, MIRApply insured and physician, claims risk adjustment, CLARA plus, data analytics, underwriting and claims, medical research, capital management, and health market.

Recommended Stories

Should You Invest $1,000 in Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München Right Now?

Before you consider Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München wasn't on the list.

While Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential
Buy Early: 3 Tech Trends With Millionaire-Making Potential
SMCI Stumbles on Earnings: Why Some Investors Still Want In

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines